Cellectis
CLLS
#7885
Rank
โ‚น29.35 B
Marketcap
โ‚น291.85
Share price
-3.45%
Change (1 day)
168.66%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: โ‚น29.35 Billion

As of March 2026 Cellectis has a market cap of โ‚น29.35 Billion. This makes Cellectis the world's 7885th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น29.35 B-31.37%
2025โ‚น42.77 B246.68%
2024โ‚น12.33 B-32.77%
2023โ‚น18.35 B126.65%
2022โ‚น8.09 B-71.6%
2021โ‚น28.51 B-69.42%
2020โ‚น93.24 B75.32%
2019โ‚น53.18 B3.93%
2018โ‚น51.17 B-20.48%
2017โ‚น64.35 B56.41%
2016โ‚น41.14 B-42.34%
2015โ‚น71.36 B157.11%
2014โ‚น27.75 B570.96%
2013โ‚น4.13 B

End of Day market cap according to different sources

On Mar 28th, 2026 the market cap of Cellectis was reported to be:

โ‚น21.18 Billion
by Nasdaq info icon info icon
โ‚น29.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚น7.390 T 25,072.84%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
โ‚น87.51 B 198.10%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚น130.46 B 344.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น43.48 B 48.13%๐Ÿ‡บ๐Ÿ‡ธ USA